Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Squamous Cell Carcinoma of Head and Neck 16Oropharyngeal Neoplasms 10Nasopharyngeal Carcinoma 10Prostatic Neoplasms 7Laryngeal Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Hypopharyngeal Neoplasms 5Head and Neck Neoplasms 5Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nasopharyngeal Neoplasms 2Mesothelioma 2Epstein-Barr Virus Infections 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Anus Neoplasms 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomatitis 1Stomach Neoplasms 1

Interventions

Gemcitabine 31pembrolizumab 20Cisplatin 20Magnetic Resonance Spectroscopy 18Specimen Handling 16durvalumab 11Mitomycin 11enfortumab vedotin 9avelumab 9Nivolumab 9Cystoscopy 9Fluorouracil 8Radiation 7Carboplatin 7Radiotherapy 6Immunoglobulin G 6Docetaxel 6Disulfides 6Cystectomy 6Transurethral Resection of Bladder 5Mitozytrex 5Biopsy 5sacituzumab govitecan 4erdafitinib 4dehydroftorafur 4atezolizumab 4Standard of Care 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Radiotherapy, Intensity-Modulated × 90 days × Clear all
NCT02316548 2026-05-22

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

NRG Oncology

Phase 2 Terminated
14 enrolled 16 charts
Genitourinary

Urinary Bladder Neoplasms

NCT07579195 2026-05-14

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

University of Washington

Phase 1/2 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡